IL15 and neoplasm: However, constitutive systemic IL-15 can provoke excessive immune activation and severe CRS; engineering solutions that have shown promise include membrane-bound IL-15, inducible expression, or tethering to the CAR to limit exposure to the tumor locale (23, 59, 60, 88).